Check out Kristin Yarema & BioCentury on “Creating CAR T therapies that don’t cause cancer"


Jeffrey W. Winkelman, Ph.D., J.D.

Senior Vice President, Chief Patent Counsel

A headshot of Jeffrey W. Winkelm.

Dr. Winkelman is our Senior Vice President, Chief Patent Counsel, after joining Poseida in October 2019 and most recently serving as Vice President, Intellectual Property. Dr. Winkelman has a wide range of experience to maximize the value of Poseida’s gene engineering technologies. He was previously Executive Director, Intellectual Property at Mirati Therapeutics, Inc. and has served in senior management positions, including Vice President, Intellectual Property at BioSante Pharmaceuticals, Cell Genesys Inc., and Elitra Pharmaceuticals. Dr Winkelman received a J.D. from the University of San Diego, a Ph.D. from the University of California, Irvine and an M.A. and B.A. in Microbiology from Southern Illinois University.

A headshot of Jeffrey W. Winkelm.